Triazole resistance surveillance in Aspergillus fumigatus.
暂无分享,去创建一个
[1] J. van Paassen,et al. Influenza-Associated Aspergillosis in Critically Ill Patients. , 2017, American journal of respiratory and critical care medicine.
[2] A. Mikos,et al. Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999–2015 , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] J. Meis,et al. Intercountry Transfer of Triazole-Resistant Aspergillus fumigatus on Plant Bulbs , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] B. Zwaan,et al. A Novel Environmental Azole Resistance Mutation in Aspergillus fumigatus and a Possible Role of Sexual Reproduction in Its Emergence , 2017, mBio.
[5] P. Le Pape,et al. Azole-resistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia , 2017, Scientific Reports.
[6] A. Chowdhary,et al. Clinical implications of globally emerging azole resistance in Aspergillus fumigatus , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.
[7] J. Cornelissen,et al. PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis. , 2016, The Journal of antimicrobial chemotherapy.
[8] B. Zwaan,et al. In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management. , 2016, The Lancet. Infectious diseases.
[9] D. Denning,et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America , 2016 .
[10] W. Melchers,et al. Azole resistance surveillance in Aspergillus fumigatus: beneficial or biased? , 2016, The Journal of antimicrobial chemotherapy.
[11] E. Kuijper,et al. Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[12] J. Meis,et al. Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[13] W. Melchers,et al. Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection. , 2016, American journal of respiratory and critical care medicine.
[14] T. Lagu,et al. Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] W. Melchers,et al. Next-Generation Sequencing in the Mycology Lab , 2016, Current Fungal Infection Reports.
[16] M. Cogliati,et al. Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection , 2015, Antimicrobial Agents and Chemotherapy.
[17] H. Fan,et al. First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States , 2015, Journal of Clinical Microbiology.
[18] J. Meis,et al. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients. , 2015, The Journal of antimicrobial chemotherapy.
[19] W. Melchers,et al. Genotype-phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus. , 2015, Fungal genetics and biology : FG & B.
[20] B. Ener,et al. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey. , 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[21] S. Seyedmousavi,et al. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[22] P. Hauser,et al. Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus , 2015, Emerging infectious diseases.
[23] J. Boelens,et al. Nationwide Surveillance of Azole Resistance in Aspergillus Diseases , 2015, Antimicrobial Agents and Chemotherapy.
[24] A. Chowdhary,et al. Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia , 2015, Front. Microbiol..
[25] J. Buer,et al. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany. , 2015, The Journal of antimicrobial chemotherapy.
[26] S. Seyedmousavi,et al. Pharmacodynamics of Isavuconazole in an Aspergillus fumigatus Mouse Infection Model , 2015, Antimicrobial Agents and Chemotherapy.
[27] J. Meis,et al. Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures. , 2015, The Journal of antimicrobial chemotherapy.
[28] J. Rello,et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes , 2015, Critical Care.
[29] G. Simons,et al. Validation of a New Aspergillus Real-Time PCR Assay for Direct Detection of Aspergillus and Azole Resistance of Aspergillus fumigatus on Bronchoalveolar Lavage Fluid , 2015, Journal of Clinical Microbiology.
[30] M. Webber,et al. Molecular mechanisms of antibiotic resistance , 2014, Nature Reviews Microbiology.
[31] D. Denning,et al. The clinical spectrum of pulmonary aspergillosis , 2014, Thorax.
[32] A. Chowdhary,et al. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms. , 2014, Future microbiology.
[33] A. Chowdhary,et al. Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India. , 2014, The Journal of antimicrobial chemotherapy.
[34] D. Andes,et al. Isavuconazole (BAL4815) Pharmacodynamic Target Determination in an In Vivo Murine Model of Invasive Pulmonary Aspergillosis against Wild-Type and cyp51 Mutant Isolates of Aspergillus fumigatus , 2013, Antimicrobial Agents and Chemotherapy.
[35] F. V. van Tiel,et al. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] D. Denning,et al. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus. , 2013, The Journal of antimicrobial chemotherapy.
[37] M. Christner,et al. cyp51A-Based Mechanisms of Aspergillus fumigatus Azole Drug Resistance Present in Clinical Samples from Germany , 2013, Antimicrobial Agents and Chemotherapy.
[38] S. Seyedmousavi,et al. Azole-Resistant Aspergillus fumigatus, Iran , 2013, Emerging infectious diseases.
[39] P. Escribano,et al. Is Azole Resistance in Aspergillus fumigatus a Problem in Spain? , 2013, Antimicrobial Agents and Chemotherapy.
[40] D. Cole,et al. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. , 2013, Medical mycology.
[41] D. Denning,et al. High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates. , 2013, The Journal of antimicrobial chemotherapy.
[42] A. Chowdhary,et al. Clonal Expansion and Emergence of Environmental Multiple-Triazole-Resistant Aspergillus fumigatus Strains Carrying the TR34/L98H Mutations in the cyp51A Gene in India , 2012, PloS one.
[43] M. Huynen,et al. Discovery of a hapE Mutation That Causes Azole Resistance in Aspergillus fumigatus through Whole Genome Sequencing and Sexual Crossing , 2012, PloS one.
[44] J. Cutright,et al. In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus. , 2012, Diagnostic microbiology and infectious disease.
[45] P. Jorens,et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study , 2012, Intensive Care Medicine.
[46] D. Cole,et al. Global burden of chronic pulmonary aspergillosis complicating sarcoidosis , 2012, European Respiratory Journal.
[47] W. Melchers,et al. Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus , 2012, PloS one.
[48] D. Cole,et al. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. , 2011, Bulletin of the World Health Organization.
[49] W. Melchers,et al. The structure-function relationship of the Aspergillus fumigatuscyp51A L98H conversion by site-directed mutagenesis: the mechanism of L98H azole resistance. , 2011, Fungal genetics and biology : FG & B.
[50] T. Nishino,et al. Antifungal Susceptibilities of Aspergillus fumigatus Clinical Isolates Obtained in Nagasaki, Japan , 2011, Antimicrobial Agents and Chemotherapy.
[51] E. Kuijper,et al. Rapid Induction of Multiple Resistance Mechanisms in Aspergillus fumigatus during Azole Therapy: a Case Study and Review of the Literature , 2011, Antimicrobial Agents and Chemotherapy.
[52] R. A. Cramer,et al. SREBP-Dependent Triazole Susceptibility in Aspergillus fumigatus Is Mediated through Direct Transcriptional Regulation of erg11A (cyp51A) , 2011, Antimicrobial Agents and Chemotherapy.
[53] F. V. van Tiel,et al. Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007–2009 , 2011, Emerging infectious diseases.
[54] S. Lockhart,et al. Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene , 2011, Antimicrobial Agents and Chemotherapy.
[55] A. Warris,et al. Aspergillus species intrinsically resistant to antifungal agents. , 2011, Medical mycology.
[56] E. Petinaki,et al. Polyphasic Identification and Susceptibility to Seven Antifungals of 102 Aspergillus Isolates Recovered from Immunocompromised Hosts in Greece , 2011, Antimicrobial Agents and Chemotherapy.
[57] R. Rajendran,et al. Azole Resistance of Aspergillus fumigatus Biofilms Is Partly Associated with Efflux Pump Activity , 2011, Antimicrobial Agents and Chemotherapy.
[58] D. Denning,et al. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. , 2010, The Journal of antimicrobial chemotherapy.
[59] W. Melchers,et al. Impact of cyp51A Mutations on the Pharmacokinetic and Pharmacodynamic Properties of Voriconazole in a Murine Model of Disseminated Aspergillosis , 2010, Antimicrobial Agents and Chemotherapy.
[60] D. Kelly,et al. Expression, Purification, and Characterization of Aspergillus fumigatus Sterol 14-α Demethylase (CYP51) Isoenzymes A and B , 2010, Antimicrobial Agents and Chemotherapy.
[61] Thomas J Walsh,et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[62] E. Anaissie,et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[63] W. Melchers,et al. Azole Resistance Profile of Amino Acid Changes in Aspergillus fumigatus CYP51A Based on Protein Homology Modeling , 2010, Antimicrobial Agents and Chemotherapy.
[64] W. Melchers,et al. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? , 2009, The Lancet. Infectious diseases.
[65] D. Denning,et al. zole-resistance in Aspergillus: Proposed nomenclature and breakpoints , 2009 .
[66] J. Baddley,et al. Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network , 2009, Journal of Clinical Microbiology.
[67] I. T. Ten Berge,et al. Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery. , 2009, Medical mycology.
[68] D. Denning,et al. Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure , 2009, Emerging infectious diseases.
[69] W. Melchers,et al. Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles , 2009, Applied and Environmental Microbiology.
[70] E. Anaissie,et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[71] W. Melchers,et al. Academic Editor: Chris Kibbler, Royal Free Hospital London, United Kingdom , 2007 .
[72] Martin Bard,et al. A Sterol-Regulatory Element Binding Protein Is Required for Cell Polarity, Hypoxia Adaptation, Azole Drug Resistance, and Virulence in Aspergillus fumigatus , 2008, PLoS pathogens.
[73] W. Melchers,et al. Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene , 2008, Antimicrobial Agents and Chemotherapy.
[74] W. Melchers,et al. Multiple-triazole-resistant aspergillosis. , 2007, The New England journal of medicine.
[75] W. Melchers,et al. A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations , 2007, Antimicrobial Agents and Chemotherapy.
[76] D. Denning,et al. Multi-azole resistance in Aspergillus fumigatus. , 2006, International journal of antimicrobial agents.
[77] E. Mellado,et al. Substitutions at Methionine 220 in the 14α-Sterol Demethylase (Cyp51A) of Aspergillus fumigatus Are Responsible for Resistance In Vitro to Azole Antifungal Drugs , 2004, Antimicrobial Agents and Chemotherapy.
[78] Michael Light,et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[79] E. Mellado,et al. A Point Mutation in the 14α-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus , 2003, Antimicrobial Agents and Chemotherapy.
[80] D. Stevens,et al. Antifungal drug resistance. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[81] Richard Sylvester,et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.
[82] E. Anaissie,et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. , 2002, The New England journal of medicine.
[83] William R. Kirkpatrick,et al. Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes , 2000, Medicine.
[84] S. Kelly,et al. Itraconazole resistance in Aspergillus fumigatus , 1997, Antimicrobial agents and chemotherapy.
[85] A. Brillowska-Dąbrowska,et al. Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles. , 2018, Medical mycology.
[86] P. Le Pape,et al. Home Environment as a Source of Life-Threatening Azole-Resistant Aspergillus fumigatus in Immunocompromised Patients. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[87] Z. Wan,et al. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. , 2005, The Journal of antimicrobial chemotherapy.
[88] A. Wilmer,et al. Invasive aspergillosis in critically ill patients without malignancy. , 2004, American journal of respiratory and critical care medicine.